Log in

OTCMKTS:PMCBPharmacyte Biotech Stock Price, Forecast & News

0.00 (0.00 %)
(As of 06/1/2020 04:00 PM ET)
Today's Range
Now: $0.02
50-Day Range
MA: $0.02
52-Week Range
Now: $0.02
Volume2.31 million shs
Average Volume4.73 million shs
Market Capitalization$31.62 million
P/E RatioN/A
Dividend YieldN/A
PharmaCyte Biotech, Inc., a clinical stage biotechnology company, focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of the cancer. It is also developing a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes; and therapies for cancer based on the constituents of the Cannabis plant. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was founded in 1996 and is based in Laguna Hills, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Current SymbolOTCMKTS:PMCB



Sales & Book Value

Annual SalesN/A


Net Income$-4,070,000.00


Outstanding Shares1,638,138,000
Market Cap$31.62 million
Next Earnings Date8/10/2020 (Estimated)
OptionableNot Optionable

Receive PMCB News and Ratings via Email

Sign-up to receive the latest news and ratings for PMCB and its competitors with MarketBeat's FREE daily newsletter.

Pharmacyte Biotech (OTCMKTS:PMCB) Frequently Asked Questions

How has Pharmacyte Biotech's stock been impacted by COVID-19 (Coronavirus)?

Pharmacyte Biotech's stock was trading at $0.0450 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PMCB shares have decreased by 57.1% and is now trading at $0.0193. View which stocks have been most impacted by Coronavirus.

When is Pharmacyte Biotech's next earnings date?

Pharmacyte Biotech is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Pharmacyte Biotech.

Has Pharmacyte Biotech been receiving favorable news coverage?

Media coverage about PMCB stock has trended very positive on Tuesday, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Pharmacyte Biotech earned a news sentiment score of 3.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutPharmacyte Biotech.

Who are some of Pharmacyte Biotech's key competitors?

What other stocks do shareholders of Pharmacyte Biotech own?

Who are Pharmacyte Biotech's key executives?

Pharmacyte Biotech's management team includes the following people:
  • Mr. Kenneth L. Waggoner, Chairman, CEO, Pres, Gen. Counsel & Sec. (Age 71)
  • Mr. Carlos A. Trujillo, CFO & Director (Age 61)
  • Dr. Gerald W. Crabtree, COO & Director (Age 78)
  • Prof. Walter H. Günzburg, Chief Scientific Officer & Consultant (Age 60)
  • Dr. Mark L. Rabe, Director of Cannabis Program Devel. and Member of Medical & Scientific Advisory Board

What is Pharmacyte Biotech's stock symbol?

Pharmacyte Biotech trades on the OTCMKTS under the ticker symbol "PMCB."

How do I buy shares of Pharmacyte Biotech?

Shares of PMCB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pharmacyte Biotech's stock price today?

One share of PMCB stock can currently be purchased for approximately $0.02.

How big of a company is Pharmacyte Biotech?

Pharmacyte Biotech has a market capitalization of $31.62 million. Pharmacyte Biotech employs 4 workers across the globe.

What is Pharmacyte Biotech's official website?

The official website for Pharmacyte Biotech is www.pharmacyte.com.

How can I contact Pharmacyte Biotech?

Pharmacyte Biotech's mailing address is 23046 AVENIDA DE LA CARLOTA SUITE 600, LAGUNA HILLS CA, 92653. The company can be reached via phone at 917-595-2850 or via email at [email protected]

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.